BCL2 and neoplasm: Morphologically, BCL2/Sestrin1-deficient tumors resembled FL with a follicular architecture, they displayed markers of a GC phenotype (PNA and BCL6), showed evidence of somatic hypermutation, an increased tumor proliferation based on Ki67 staining.